Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
666-03-010 ISMRM Abstract

Striatal Microstructural Alterations Revealed by NEXI in a Mouse Model of Glucose Transporter-1 Deficiency Syndrome

Primary: Diffusion - Microstructure
Secondary: Preclinical Animal & in vitro MR - Gray Matter
666-03-010 · Neuro-Biomarkers · Thursday, 14 May, 1:40 PM–2:35 PM · Digital Posters Row G
Keywords: Animal mouse model Microstructural alterations Diffusion Biophysical Modeling Neurometabolic disorder Diffusion in Gray Matter
Accepted
Andreea Hertanu 1, Sophie Burlet-Godinot2, Daphné Vorburger2, Hubert Fiumelli3, Jean-Luc Martin2, Pierre J Magistretti2,3, Ileana Jelescu1
1Department of Radiology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland
2Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital (CHUV), Prilly, Switzerland
3Division of Biological and Environmental Sciences and Engineering, KAUST, Thuwal, Saudi Arabia
Presenting Author: Andreea Hertanu

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. 1. Vivo DCD, Trifiletti RR, Jacobson RI, Ronen GM, Behmand RA, Harik SI. Defective Glucose Transport across the Blood-Brain Barrier as a Cause of Persistent Hypoglycorrhachia, Seizures, and Developmental Delay. N Engl J Med. 1991;325(10):703-709. doi:10.1056/NEJM199109053251006 [doi]
2. 2. Wang D, Sands T, Tang M, Monani U, De Vivo D. Glucose Transporter Type 1 Deficiency Syndrome. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, eds. GeneReviews®. Seattle (WA): University of Washington, Seattle; 1993. http://www.ncbi.nlm.nih.gov/books/NBK1430/.
3. 3. Klepper J, Akman C, Armeno M, et al. Glut1 Deficiency Syndrome (Glut1DS): State of the art in 2020 and recommendations of the international Glut1DS study group. Epilepsia Open. 2020;5(3):354-365. doi:10.1002/epi4.12414 [doi]
4. 4. Jelescu IO, de Skowronski A, Geffroy F, Palombo M, Novikov DS. Neurite Exchange Imaging (NEXI): A minimal model of diffusion in gray matter with inter-compartment water exchange. NeuroImage. 2022;256:119277. doi:10.1016/j.neuroimage.2022.119277 [doi]
5. 5. Moeller S, Pisharady PK, Ramanna S, et al. NOise reduction with DIstribution Corrected (NORDIC) PCA in dMRI with complex-valued parameter-free locally low-rank processing. NeuroImage. 2021;226:117539. doi:10.1016/j.neuroimage.2020.117539 [doi]
6. 6. Kellner E, Dhital B, Kiselev VG, Reisert M. Gibbs-ringing artifact removal based on local subvoxel-shifts. Magn Reson Med. 2016;76(5):1574-1581. doi:10.1002/mrm.26054 [doi]
7. 7. Andersson JLR, Skare S, Ashburner J. How to correct susceptibility distortions in spin-echo echo-planar images: application to diffusion tensor imaging. NeuroImage. 2003;20(2):870-888. doi:10.1016/S1053-8119(03)00336-7 [doi]
8. 8. Andersson JLR, Sotiropoulos SN. An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging. NeuroImage. 2016;125:1063-1078. doi:10.1016/j.neuroimage.2015.10.019 [doi]
9. 9. Veraart J, Fieremans E, Novikov DS. Diffusion MRI noise mapping using random matrix theory. Magn Reson Med. 2016;76(5):1582-1593. doi:10.1002/mrm.26059 [doi]
10. 10. Uhl Q, Pavan T, Feiweier T, Piredda GF, Jelescu I. Human gray matter microstructure mapped using neurite exchange imaging (NEXI) on a clinical scanner. Imaging Neurosci Camb Mass. 2025;3:IMAG.a.32. doi:10.1162/IMAG.a.32 [doi]
11. 11. Schilling KG, Howard AFD, Grussu F, et al. Considerations and recommendations from the ISMRM Diffusion Study Group for preclinical diffusion MRI: Part 3-Ex vivo imaging: Data processing, comparisons with microscopy, and tractography. Magn Reson Med. 2025;93(6):2561-2582. doi:10.1002/mrm.30424 [doi]
12. 12. Schilling KG, Grussu F, Ianus A, et al. Considerations and recommendations from the ISMRM diffusion study group for preclinical diffusion MRI: Part 2-Ex vivo imaging: Added value and acquisition. Magn Reson Med. 2025;93(6):2535-2560. doi:10.1002/mrm.30435 [doi]
13. 13. Veraart J, Sijbers J, Sunaert S, Leemans A, Jeurissen B. Weighted linear least squares estimation of diffusion MRI parameters: Strengths, limitations, and pitfalls. NeuroImage. 2013;81:335-346. doi:10.1016/j.neuroimage.2013.05.028 [doi]
14. 14. Avants BB, Tustison N, Song G. Advanced Normalization Tools (ANTS). Insight J. 2009;2:1-35.
15. 15. Wilhelmsson U, Bushong EA, Price DL, et al. Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury. Proc Natl Acad Sci U S A. 2006;103(46):17513-17518. doi:10.1073/pnas.0602841103 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/666-03-010